8 completed, 3 terminated, 3 unknown, 3 withdrawn. 19 Phase 2, 4 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 8, Terminated 3, Unknown 3, Withdrawn 3, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
Follow Steroid: new trials by email Literature Review of Steroid trials Research Report on Steroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis Steroid, Antibiotic - Granulomatous Mastitis | Phase 1 / Phase 2 | Not yet recruiting | All India Institute of Medical Sciences, Bhubaneswar | 72 | 2026-03-15 | 2026-03-06 |
| Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss Hydroxychloroquine, Steroid - Sudden Hearing Loss | Phase 2 | Recruiting | Chang Gung Memorial Hospital | 80 | 2024-09-10 | 2026-10-22 |
| Steroids for Early Treatment of Radiation Retinopathy Fluocinolone Acetonide (FA) implant - Radiation Retinopathy | Phase 2 / Phase 3 | Withdrawn | The Cleveland Clinic | 2022-02-01 | 2021-08-04 | |
| Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis Mycophenolate Mofetil, Solu-Medrol, Ursodeoxycholic acid - Hepatitis, Drug-Induced | Phase 2 | Unknown | Inge Marie Svane | 60 | 2021-04-07 | 2022-12-14 |
| Follow-up and Steroid Treatment Results in Intussusception Methylprednisolone - Intussusception | Phase 1 / Phase 2 | Completed | Baskent University | 92 | 2019-12-24 | 2025-02-05 |
| Ruxolitinib Plus LVP in Patients With R/R ETP-ALL Ruxolitinib, Vincristine, Prednisone - Acute T Cell Leukemia | Phase 1 / Phase 2 | Unknown | Sichuan University | 12 | 2018-12-01 | 2018-08-03 |
| Ruxolitinib and Steroid As First Line Therapy for Acute GVHD Ruxolitinib Oral Tablet, Methylprednisolone - Acute GVHD | Phase 2 | Terminated | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 | 2018-11-01 | 2024-10-01 |
| Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy Rolapitant, Palonosetron, Olanzapine - Germ Cell Tumor | Phase 2 | Withdrawn | Costantine Albany | 2018-05-01 | 2019-05-22 | |
| Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone - Multiple Myeloma in Relapse | Phase 2 | Completed | Raija Silvennoinen | 15 | 2017-08-07 | 2023-09-26 |
| Combination Study for High Risk Multiple Myeloma Patients Elotuzumab, Pomalidomide, Carfilzomib - Multiple Myeloma | Phase 2 | Terminated | Oncotherapeutics | 13 | 2017-03-13 | 2022-03-31 |
| RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone Iron sucrose, Oxandrolone, IV iron placebo - Functional Iron Deficiency, Trauma | Phase 2 | Withdrawn | Denver Health and Hospital Authority | 2015-01-01 | 2019-04-03 | |
| Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Natalizumab, Methylprednisolone - Graft Versus Host Disease | Phase 2 | Completed | Dana-Farber Cancer Institute | 21 | 2015-01-01 | 2020-04-17 |
| A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 191 | 2014-05-01 | 2022-10-07 |
| Eosinophilic Esophagitis Clinical Therapy Comparison Trial Oral Budesonide, Elimination diet - Eosinophilic Esophagitis | Phase 2 | Terminated | Baylor College of Medicine | 3 | 2013-07-09 | 2021-01-11 |
| Efficacy of Steroid Supplementation After TMJ Rinsing for Pain Management Lactated Ringers, Triamcinolone hexacetonide - Pain | Phase 2 | Completed | University of Florida | 24 | 2013-03-01 | 2020-10-08 |
| Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis MRX-6, Steroid - Allergic Contact Dermatitis | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 13 | 2011-03-01 | 2015-04-21 |
| Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma Immunochemotherapy, High-dose BEAM plus autologous SCT, HLA-identical allogenic SCT - Mantle-Cell Lymphoma | Phase 2 | Unknown | Heidelberg University | 20 | 2004-07-01 | 2009-07-27 |
| Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX tacrolimus, Anti-IL2R AB, Mycophenolate mofetil - Liver Transplantation | Phase 2 | Completed | Astellas Pharma Inc | 94 | 2002-11-01 | 2014-08-26 |
| S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma filgrastim, sargramostim, cyclophosphamide - Multiple Myeloma | Phase 2 | Completed | SWOG Cancer Research Network | 147 | 2002-06-01 | 2016-12-08 |
Multiple Myeloma (2) · Anemia (1) · Aspergillosis, Allergic Bronchopulmonary (1) · Chemical and Drug Induced Liver Injury (1) · Deglutition Disorders (1) · Dermatitis, Allergic Contact (1) · Dermatitis, Contact (1) · Eczema (1) · Eosinophilic Esophagitis (1) · Facial Pain (1) · Food Hypersensitivity (1) · Gastroesophageal Reflux (1) · Graft vs Host Disease (1) · Granulomatous Mastitis (1) · Hearing Loss, Sudden (1)
All India Institute of Medical Sciences, Bhubaneswar (1) · Astellas Pharma Inc (1) · Baskent University (1) · Baylor College of Medicine (1) · Chang Gung Memorial Hospital (1) · Costantine Albany (1) · Dana-Farber Cancer Institute (1) · Denver Health and Hospital Authority (1) · Hadassah Medical Organization (1) · Heidelberg University (1) · Inge Marie Svane (1) · Oncotherapeutics (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Raija Silvennoinen (1) · SWOG Cancer Research Network (1)
United States (7) · India (2) · China (1) · Denmark (1) · Finland (1) · Germany (1) · Israel (1) · Italy (1) · Sweden (1) · Taiwan (1) · Turkey (Türkiye) (1)
Anthony D. Ho, Ph.D., Prof. (1) · Carla M. Davis, MD (1) · Chao-Hui Yang (1) · Charles G. Widmer, DDS, MS (1) · Corey Cutler, MD, MPH (1) · Costantine Albany, MD (1) · Fredric M Pieracci, MD, MPH (1) · Inge M Svane (1) · James R Berenson, MD (1) · Jie Ji, MD (1) · Mohamad A. Hussein, MD (1) · Raija Silvennoinen, MD, PhD (1)
PMID 17346444, PMID 19546405, PMID 34818965, PMID 39914152, PMID 41786454
2016 (1), U10CA032102 (1)